Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
OPKO Health Inc
OPK
Healthcare
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product...
sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:OPK)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(276)
•••
whytestocks
X
Post by
whytestocks
on Sep 17, 2024 6:02pm
Overweight Recommendation Issued On OPK By Piper Sandler
Breaking News: $OPK Overweight Recommendation Issued On OPK By Piper Sandler2024-09-17 12:15:08 ET Piper Sandler analyst issues OVERWEIGHT recommendation for OPK on September 17, 2024 07:15AM ET. The
...more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 7:50pm
OPKO Health, Inc. (NASDAQ:OPK): Diversified Healthcare Compa
https://beyondspx.com/2024/08/01/opko-health-inc-nasdaqopk-diversified-healthcare-company-streamlining-operations-and-advancing-promising-pipeline/
(96)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jul 19, 2024 10:45am
This pharmacist stock and biotech stock was
Bought by me at the beginning of this year.As usual for me,it was a boat load of shares :100000 shares at .90cents/share which was near its all time low of .85 cents per share and it's all time
...more
(59)
•••
Nibinator
X
Post by
Nibinator
on Mar 31, 2024 9:05pm
BUY BUY BUY BUY BUY
I starting the day with this ... high hopes sings frankie boy
(276)
•••
whytestocks
X
Post by
whytestocks
on Aug 04, 2023 1:15am
Opko Health (OPK) Q2 2023 Earnings Call Transcript
BREAKING NEWS: $OPK Opko Health (OPK) Q2 2023 Earnings Call Transcript2023-08-04 01:00:22 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q2 2023 Earnings Call Aug 03, 2023 , 4:30
...more
(0)
•••
Irene89
X
Post by
Irene89
on Apr 13, 2023 3:38am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
Irene89
X
Post by
Irene89
on Jul 15, 2022 9:16pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
Irene89
X
Post by
Irene89
on Jun 03, 2022 4:56am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
Irene89
X
Post by
Irene89
on Jun 02, 2022 12:12am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
Irene89
X
Post by
Irene89
on May 11, 2022 1:21am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
Irene89
X
Post by
Irene89
on Apr 30, 2022 3:04am
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
Irene89
X
Post by
Irene89
on Apr 22, 2022 12:30am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
Irene89
X
Post by
Irene89
on Apr 16, 2022 3:32am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
Irene89
X
Post by
Irene89
on Apr 09, 2022 1:59am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
Irene89
X
Post by
Irene89
on Apr 07, 2022 12:06pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Debt-Free Cannabis Company Set for Next Stage of Growth
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Rig Count Soars as Utilization Surpasses Industry Averages
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments